Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nexalin Technology Inc (NXL)

Nexalin Technology Inc (NXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nexalin Technology Inc 1776 YORKTOWN SUITE 550 Houston TX 77056 USA

www.nexalin.com Employees: 6 P: 832-260-0222

INDUSTRY GROUPING:

Technology Services

Description:

Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas.

Key Statistics

Overview:

Market Capitalization, $K 8,558
Enterprise Value, $K 7,988
Shares Outstanding, K 18,652
Float, K 13,941
% Float 74.74%
Short Interest, K 147
Short Float 0.79%
Days to Cover 1.34
Short Volume Ratio 0.67
% of Insider Shareholders 25.26%
% of Institutional Shareholders 0.65%

Financials:

Annual Sales, $ 170 K
Annual Net Income, $ -7,610 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -2,280 K
EBIT, $ -7,660 K
EBITDA, $ -7,640 K

Growth:

1-Year Return -85.63%
3-Year Return -47.75%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/14/25
Next Earnings Date 03/13/26 [--]
Earnings Per Share ttm -0.66
EPS Growth vs. Prev Qtr -30.00%
EPS Growth vs. Prev Year 43.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NXL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -207.46%
Return-on-Assets % -184.51%
Profit Margin % -4,476.47%
Debt/Equity 0.00
Price/Sales 43.37
Price/Cash Flow N/A
Price/Book 1.48
Book Value/Share 0.27
Interest Coverage -0.14
60-Month Beta 3.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar